{
    "2021-12-07": [
        [
            {
                "time": "",
                "original_text": "医药行业2022年投资策略报告：政策扰动下分化加剧 战略性看好医药黄金赛道上的优质个股",
                "features": {
                    "keywords": [
                        "医药行业",
                        "2022年",
                        "投资策略",
                        "政策扰动",
                        "分化加剧",
                        "黄金赛道",
                        "优质个股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}